Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran



Mirnasseri MM1 ; Poustchi H1 ; Nasserimoghadam S1 ; Tavakkoli H2, 3 ; Mohammadkhani A1 ; Afshar P1 ; Malekzadeh R1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Digestive Disease Research Center, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran
  2. 2. Department of Gastroenterology, Isfahan University of Medical Science, Isfahan, Iran
  3. 3. Department of Gastroenterology, Alzahra University Hospital, Isfahan, Sofeh Avenue, Iran

Source: Journal of Research in Medical Sciences Published:2008

Abstract

Background: Hepatitis C (HCV) is increasing worldwide including Iran. HCV is more prevalent among intravenous drug abusers (IDU), especially if imprisoned, mostly due to needle sharing. We determined the rate of HCV seropositivity among IDU prisoners and compared it with those of non-prisoners. Methods: A cross-sectional study was conducted on consenting IDUs inhabiting two prisons and attending three rehabilitation centers in Tehran, Iran. A questionnaire was completed for each subject and 5 ml blood was drawn. The samples were kept at 2-8°c until the sera were separated and stored at -70°c. HCVAb (ELISA) was checked by a single technician. Chi-square, Fisher's exact test and multivariate analysis were used where appropriate. Results: Five-hundred and eighteen subjects were enrolled. About 74.5% were prisoners and 89.6% were male. Overall, 59.5% were positive for HCVAb (93.2% males and 6.8% females, P < 0.02). HCV seropositivity was higher among prisoners compared to non-prisoners (78.3% vs. 30.6%, respectively, P < 0.001). Also, it was higher in IUD older than 45 year-old compared to those younger than 30 year-old (77.8% vs. 54.2%, respectively, P = 0.002). Multivariate analysis showed significant association of HCV seropositivity with imprisonment (OR: 9.32, 95% CI: 5.60-15.51), sharing syringes (OR: 2.00, 95% CI: 1.26-3.17) and duration of intravenous drug use (OR: 0.86, 95% CI: 0.80-0.92). Conclusions: HCV is rather common among IDU prisoners. Imprisomnent is an independent risk factor for HCV and the infected IDUs going back to the society could be an important source of HCV. Taking effective strategies (education of high risk groups, provision of sterile syringes, identification and treatment of infected IDUs) to reduce the risk of this public health problem is needed urgently.
Other Related Docs
16. Hepatitis C in Correctional Centers: A Useful Experience, Journal of Isfahan Medical School (2011)
26. Assessment of Hepatitis C Risk Factors in Center of Iran: A Case-Control Study, Journal of Research in Medical Sciences (2018)
28. Prevalence of Anti Hcv Infection in Patients With Beta-Thalassemia in Isfahan-Iran, International Journal of Preventive Medicine (2012)
30. Hepatitis C Virus Infection in Patients With Hemophilia in Isfahan, Iran, International Journal of Preventive Medicine (2012)
40. Seroprevalence of Hepatitis B in Nahavand, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2006)
43. Prevalence of Hepatitis B Virus Infection in Isfahan Province, International Journal of Preventive Medicine (2014)